Edgewise Therapeutics, Inc. (EWTX) Operating cash flow 2020–2025
Edgewise Therapeutics, Inc. (EWTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$143.8MFY2025 · since FY2020: -$14.6M → -$143.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$143.8M | -31.9% |
| FY2024 | -$109.0M | -18.6% |
| FY2023 | -$91.9M | -74.7% |
| FY2022 | -$52.6M | -57.1% |
| FY2021 | -$33.5M | -129.0% |
| FY2020 | -$14.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice